Medicine, Health Care and Philosophy 16 (3):327-339 (2013)
AbstractGermany has just started a public debate on priority-setting, rationing and cost-effectiveness due to the cost explosion within the German health care system. To date, the costs for German health care run at 11,6 % of its Gross Domestic Product (GDP, 278,3 billion €) that represents a significant increase from the 5,9 % levels present in 1970. In response, the German Parliament has enacted several major and minor legal reforms over the last three decades for the sake of cost containment and maintaining stability of the health care system. The Statutory Health Insurance—SHI (Gesetzliche Krankenversicherung—GKV) is based on the fundamental principle of solidarity and provides an ethical and legal framework for implementing equity, comprehensiveness and setting the principles and rules for financing and providing health care services and benefits. Within the SHI system, several major actors can be identified: the Federal Ministry of Health, the 16 state ministries of health, the Federal Joint Committee (G-BA), the physicians (with their associations) and the hospitals (with their organizations) on the provider side, and the sickness funds with their associations on the purchasers’ side. This article reviews the structure and complexities of the German health care system with its major players and participants. The focus will be put on relevant ethical, legal and economic aspects for prioritization, rationalization, rationing and cost-effectiveness of medical benefits and services. In conclusion, this article pleads for open discussion on the challenging subject of priority-setting instead of accepting the implicit and non-transparent rationing of medical services that currently occurs at many different levels within the health care system, as it stands today
Similar books and articles
Decisions on Inclusion in the Swedish Basic Health Care Package—Roles of Cost-Effectiveness and Need.Lars Bernfort - 2003 - Health Care Analysis 11 (4):301-308.
The Significance of the Goal of Health Care for the Setting of Priorities.Per-Erik Liss - 2003 - Health Care Analysis 11 (2):161-169.
An Ethical Framework for Rationing Health Care.N. S. Jecker & R. A. Pearlman - 1992 - Journal of Medicine and Philosophy 17 (1):79-96.
Age-Rationing in Health Care: Flawed Policy, Personal Virtue.Larry R. Churchill - 2005 - Health Care Analysis 13 (2):137-146.
Impartiality and Disability Discrimination.Greg Bognar - 2011 - Kennedy Institute of Ethics Journal 21 (1):1-23.
Priority Setting in Health Care: Trends and Models From Scandinavian Experiences. [REVIEW]Bjørn Hofmann - 2013 - Medicine, Health Care and Philosophy 16 (3):349-356.
Ethics of Resource Allocation: Instruments for Rational Decision Making in Support of a Sustainable Health Care.Claudia Wild - 2005 - Poiesis and Praxis 3 (4):296-309.
Key Concepts in Health Care Priority Setting.Rogeer Hoedemaekers & Wim Dekkers - 2003 - Health Care Analysis 11 (4):309-323.
An Ethical Analysis of International Health Priority-Setting.Nuala Kenny & Christine Joffres - 2008 - Health Care Analysis 16 (2):145-160.
Inequalities in Health, Inequalities in Health Care: Four Generations of Discussion About Justice and Cost-Effectiveness Analysis.Madison Powers & Ruth R. Faden - 2000 - Kennedy Institute of Ethics Journal 10 (2):109-127.
Health and Efficiency: Clinical Effectiveness Dissected. [REVIEW]M. Keaney & A. R. Lorimer - 1998 - Health Care Analysis 6 (3):208-215.
Added to PP
Historical graph of downloads
Citations of this work
The Proposal of Philosophical Basis of the Health Care System.Andrzej Bielecki & Sylwia Nieszporska - 2017 - Medicine, Health Care and Philosophy 20 (1):23-35.
International Experiences with Priority Setting in Healthcare.Bert Gordijn & Henk ten Have - 2013 - Medicine, Health Care and Philosophy 16 (3):325-326.
References found in this work
Marginale Wirksamkeit als Posteriorisierungskriterium – Begriffsklärungen und ethisch relevante Vorüberlegungen.Dr med Alena M. Buyx, Daniel R. Friedrich & Prof Dr Bettina Schöne-Seifert - 2009 - Ethik in der Medizin 21 (2):89-100.
Marginale Wirksamkeit als Posteriorisierungskriterium – Begriffsklärungen und ethisch relevante Vorüberlegungen.Alena M. Buyx, Daniel R. Friedrich & Bettina Schöne-Seifert - 2009 - Ethik in der Medizin 21 (2):89-100.